JP2005500390A - Kgfポリペプチド組成物 - Google Patents

Kgfポリペプチド組成物 Download PDF

Info

Publication number
JP2005500390A
JP2005500390A JP2003521814A JP2003521814A JP2005500390A JP 2005500390 A JP2005500390 A JP 2005500390A JP 2003521814 A JP2003521814 A JP 2003521814A JP 2003521814 A JP2003521814 A JP 2003521814A JP 2005500390 A JP2005500390 A JP 2005500390A
Authority
JP
Japan
Prior art keywords
kgf
amino acid
des1
polypeptide
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500390A5 (cg-RX-API-DMAC7.html
Inventor
デニス ジェイ. ゴスポダロビッツ,
ダブリュー. マイケル カバノー,
ケニス クローフォード,
Original Assignee
カイロン コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23217561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2005500390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by カイロン コーポレイション filed Critical カイロン コーポレイション
Publication of JP2005500390A publication Critical patent/JP2005500390A/ja
Publication of JP2005500390A5 publication Critical patent/JP2005500390A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2003521814A 2001-08-21 2002-08-21 Kgfポリペプチド組成物 Pending JP2005500390A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009119866A Division JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Publications (2)

Publication Number Publication Date
JP2005500390A true JP2005500390A (ja) 2005-01-06
JP2005500390A5 JP2005500390A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23217561

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003521814A Pending JP2005500390A (ja) 2001-08-21 2002-08-21 Kgfポリペプチド組成物
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Country Status (8)

Country Link
US (2) US7265089B2 (cg-RX-API-DMAC7.html)
EP (1) EP1429799A4 (cg-RX-API-DMAC7.html)
JP (2) JP2005500390A (cg-RX-API-DMAC7.html)
AU (1) AU2002326742B2 (cg-RX-API-DMAC7.html)
CA (1) CA2457781A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001526A (cg-RX-API-DMAC7.html)
PL (1) PL374269A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003016505A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012000865A2 (pt) * 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0555205T3 (da) 1989-01-31 2001-03-05 Jeffrey S Rubin DNA, der koder for en væstfaktor, som er specifik for epitelceller
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5814605A (en) 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
NZ266622A (en) 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
SI0785950T1 (en) 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
EP0804479B1 (en) * 1994-10-13 2006-10-11 Amgen Inc., Method of treating diabetes mellitus using kgf
DK0785949T3 (da) * 1994-10-13 2003-08-18 Amgen Inc Fremgangsmåde til oprensning af keratinocytvækstfaktorer
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
ES2181054T3 (es) * 1996-12-06 2003-02-16 Amgen Inc Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.

Also Published As

Publication number Publication date
CA2457781A1 (en) 2003-02-27
JP2009221207A (ja) 2009-10-01
US7265089B2 (en) 2007-09-04
PL374269A1 (en) 2005-10-03
WO2003016505A2 (en) 2003-02-27
US20080200378A1 (en) 2008-08-21
EP1429799A4 (en) 2005-12-21
MXPA04001526A (es) 2004-05-31
US20030109439A1 (en) 2003-06-12
WO2003016505A3 (en) 2004-01-08
EP1429799A2 (en) 2004-06-23
AU2002326742B2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
US7138374B2 (en) Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137
JP5241037B2 (ja) 截形グリア細胞系由来神経栄養因子
KR100574387B1 (ko) 포유류 시토카인 유사 폴리펩티드-10
PT99565B (pt) Processo para a preparacao de factores de crescimento de fibroblastos quimerico s
JPH05503003A (ja) 潜在性関与ペプチドおよびその使用
CN1143386A (zh) 转化生长因子α-H1
CN109535243B (zh) 人肝细胞生长因子突变体及其应用
JPH09500267A (ja) 増加した生物学的活性を有する短縮型ケラチノサイト増殖因子(kgf)
JP2009221207A (ja) Kgfポリペプチド組成物
BG108111A (bg) Полимерни конюгати на неубластин и методи за тяхното използване
WO2002041911A2 (en) Use of fgf-19 for inhibiting angiogenesis
EP1248844B1 (en) Analogs of human basic fibroblast growth factor
SK43297A3 (en) Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
AU2002326742A1 (en) KGF polypeptide compositions
US20250277009A1 (en) Hhip-fc fusion proteins and uses thereof
AU2007214362B2 (en) KGF polypeptide compositions
US6835381B1 (en) Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor
JPWO2009116529A1 (ja) ポリペプチドおよび当該ポリペプチドを含む医薬組成物
JP2553425B2 (ja) トロンビン結合性物質及びその製造法
CA2079291A1 (en) Activities of heparin binding neurite-outgrowth promoting factor
WO2002060163A2 (en) Methods for increasing bone formation and enhancing bone accretion
HK1147502A (en) Polypeptide and pharmaceutical composition containing the polypeptide
JP2009100747A (ja) トランスフォーミング増殖因子αHII
JP2006087443A (ja) トランスフォーミング増殖因子αHII
HK1021823B (en) Truncated glial cell line-derived neurotrophic factor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050811

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050811

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090115

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090518

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090731

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20090918